Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin in amnestic mild cognitive impairment
2008-002226-11Phase 3Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD) comparing Simvastatin with Placebo (2 arms). Primary endpoint: Change in CDR-SOB at 24 months. Started Sep 2008; status: completed.
02
Drugs
simvastatin
03
Conditions
Mild Cognitive Impairment (MCI)Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2008-002226-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002226-11.